|Articles|October 1, 2003
- Pharmaceutical Executive-10-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
about 22 years ago
Balanced Scorecard for R&Dabout 22 years ago
Pharma's Value Propositionabout 22 years ago
Sharing IP, Sharing RiskNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
Report: Richard Pazdur Out as Director of CDER
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
4
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
5
